• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全外显子组测序和生物信息学分析揭示了伴有和不伴有良性甲状腺肿背景的甲状腺乳头状癌患者基因突变谱的差异。

Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.

机构信息

Department of Molecular Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.

Department of Biomedical Science, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Kuantan, Pahang, Malaysia.

出版信息

Front Endocrinol (Lausanne). 2023 Jan 4;13:1039494. doi: 10.3389/fendo.2022.1039494. eCollection 2022.

DOI:10.3389/fendo.2022.1039494
PMID:36686473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9846740/
Abstract

BACKGROUND

Papillary thyroid cancer (PTC) is the most common thyroid malignancy. Concurrent presence of cytomorphological benign thyroid goitre (BTG) and PTC lesion is often detected. Aberrant protein profiles were previously reported in patients with and without BTG cytomorphological background. This study aimed to evaluate gene mutation profiles to further understand the molecular mechanism underlying BTG, PTC without BTG background and PTC with BTG background.

METHODS

Patients were grouped according to the histopathological examination results: (i) BTG patients (n = 9), (ii) PTC patients without BTG background (PTCa, n = 8), and (iii) PTC patients with BTG background (PTCb, n = 5). Whole-exome sequencing (WES) was performed on genomic DNA extracted from thyroid tissue specimens. Nonsynonymous and splice-site variants with MAF of ≤ 1% in the 1000 Genomes Project were subjected to principal component analysis (PCA). PTC-specific SNVs were filtered against OncoKB and COSMIC while novel SNVs were screened through dbSNP and COSMIC databases. Functional impacts of the SNVs were predicted using PolyPhen-2 and SIFT. Protein-protein interaction (PPI) enrichment of the tumour-related genes was analysed using Metascape and MCODE algorithm.

RESULTS

PCA plots showed distinctive SNV profiles among the three groups. OncoKB and COSMIC database screening identified 36 tumour-related genes including and in all groups. and 19 additional genes were found only in PTCa and PTCb. "Pathways in cancer", "DNA repair" and "Fanconi anaemia pathway" were among the top networks shared by all groups. However, signalling pathways related to tyrosine kinases were the most significantly enriched in PTCa while "Jak-STAT signalling pathway" and "Notch signalling pathway" were the only significantly enriched in PTCb. Ten SNVs were PTC-specific of which two were novel; c.2786C>G (p.Ala929Gly) and c.8735G>C (p.Ser2912Thr). Four out of the ten SNVs were unique to PTCa.

CONCLUSION

Distinctive gene mutation patterns detected in this study corroborated the previous protein profile findings. We hypothesised that the PTCa and PTCb subtypes differed in the underlying molecular mechanisms involving tyrosine kinase, Jak-STAT and Notch signalling pathways. The potential applications of the SNVs in differentiating the benign from the PTC subtypes requires further validation in a larger sample size.

摘要

背景

甲状腺乳头状癌(PTC)是最常见的甲状腺恶性肿瘤。常发现细胞学良性甲状腺肿(BTG)和 PTC 病变同时存在。先前有报道称,伴有和不伴有 BTG 细胞学背景的患者存在异常的蛋白谱。本研究旨在评估基因突变谱,以进一步了解 BTG、无 BTG 背景的 PTC 和有 BTG 背景的 PTC 背后的分子机制。

方法

根据组织病理学检查结果将患者分为以下几组:(i)BTG 患者(n=9),(ii)无 BTG 背景的 PTC 患者(PTCa,n=8)和(iii)有 BTG 背景的 PTC 患者(PTCb,n=5)。从甲状腺组织标本中提取基因组 DNA 进行全外显子组测序(WES)。将在 1000 基因组计划中的 MAF≤1%的非同义突变和剪接位点变异进行主成分分析(PCA)。通过 OncoKB 和 COSMIC 数据库筛选 PTC 特异性 SNVs,通过 dbSNP 和 COSMIC 数据库筛选新的 SNVs。使用 PolyPhen-2 和 SIFT 预测 SNVs 的功能影响。使用 Metascape 和 MCODE 算法分析肿瘤相关基因的蛋白-蛋白相互作用(PPI)富集情况。

结果

PCA 图谱显示三组之间存在独特的 SNV 图谱。OncoKB 和 COSMIC 数据库筛选出所有组均含有的 36 个肿瘤相关基因,包括 和 。在 PTCa 和 PTCb 中还发现了 和另外 19 个基因。“癌症途径”、“DNA 修复”和“范可尼贫血途径”是所有组共有的顶级网络之一。然而,与酪氨酸激酶相关的信号通路在 PTCa 中最为显著富集,而“Jak-STAT 信号通路”和“Notch 信号通路”是 PTCb 中唯一显著富集的通路。10 个 SNVs 是 PTC 特异性的,其中 2 个是新的; c.2786C>G (p.Ala929Gly) 和 c.8735G>C (p.Ser2912Thr)。这 10 个 SNVs 中有 4 个是 PTCa 特有的。

结论

本研究中检测到的独特基因突变模式与先前的蛋白谱发现相符。我们假设 PTCa 和 PTCb 亚型在涉及酪氨酸激酶、Jak-STAT 和 Notch 信号通路的潜在分子机制上存在差异。这些 SNVs 在区分良性和 PTC 亚型中的潜在应用需要在更大的样本量中进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/40eb87d9f3bd/fendo-13-1039494-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/9ca4f9fec3cf/fendo-13-1039494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/cdac29432bfe/fendo-13-1039494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/b499d666572b/fendo-13-1039494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/659086e106ed/fendo-13-1039494-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/7d9f8b9d75bf/fendo-13-1039494-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/40eb87d9f3bd/fendo-13-1039494-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/9ca4f9fec3cf/fendo-13-1039494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/cdac29432bfe/fendo-13-1039494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/b499d666572b/fendo-13-1039494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/659086e106ed/fendo-13-1039494-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/7d9f8b9d75bf/fendo-13-1039494-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79db/9846740/40eb87d9f3bd/fendo-13-1039494-g006.jpg

相似文献

1
Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.全外显子组测序和生物信息学分析揭示了伴有和不伴有良性甲状腺肿背景的甲状腺乳头状癌患者基因突变谱的差异。
Front Endocrinol (Lausanne). 2023 Jan 4;13:1039494. doi: 10.3389/fendo.2022.1039494. eCollection 2022.
2
A mutation panel comprising BRAF, NRAS, and NRAS replicated retrospective histopathological examination findings in differentiating benign goitre from malignant papillary thyroid cancer in a cohort of Malaysian patients.BRAF、NRAS 和 NRAS 突变panel 可复制回顾性组织病理学检查结果,有助于区分马来西亚患者队列中的良性甲状腺肿和恶性甲状腺乳头状癌。
Malays J Pathol. 2023 Dec;45(3):375-390.
3
Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer.抗氧化状态和DNA修复能力的变化与甲状腺乳头状癌患者恶性甲状腺组织中的分子改变相互印证。
Front Mol Biosci. 2023 Aug 24;10:1237548. doi: 10.3389/fmolb.2023.1237548. eCollection 2023.
4
The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.通过全外显子组测序检测到的甲状腺乳头状癌基因突变图谱。
Cell Physiol Biochem. 2018;50(1):169-178. doi: 10.1159/000493966. Epub 2018 Oct 2.
5
Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins.伴有和不伴有良性背景的甲状腺乳头状癌患者的组织和血清样本显示出不同的蛋白质表达改变。
PeerJ. 2016 Sep 13;4:e2450. doi: 10.7717/peerj.2450. eCollection 2016.
6
Novel somatic alterations underlie Chinese papillary thyroid carcinoma.中国甲状腺乳头状癌的新体细胞改变。
Cancer Biomark. 2020;27(4):445-460. doi: 10.3233/CBM-191200.
7
Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.全外显子组测序分析台湾地区甲状腺乳头状癌患者的基因突变图谱。
Hum Pathol. 2018 Aug;78:151-158. doi: 10.1016/j.humpath.2018.04.023. Epub 2018 May 9.
8
Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.识别甲状腺乳头状癌中的 LMO7-BRAF 融合基因。
Thyroid. 2018 Jun;28(6):748-754. doi: 10.1089/thy.2017.0258. Epub 2018 May 16.
9
High Prevalence of Gene Fusions and Copy Number Alterations in Pediatric Radiation Therapy-Induced Papillary and Follicular Thyroid Carcinomas.儿童放射治疗诱发的乳头状和滤泡状甲状腺癌中基因融合和拷贝数改变的高发生率
Thyroid. 2022 Apr;32(4):411-420. doi: 10.1089/thy.2021.0217.
10
iTRAQ analysis of urinary proteins: Potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma.尿液蛋白质的iTRAQ分析:凝溶胶蛋白和骨桥蛋白在鉴别良性甲状腺肿与甲状腺乳头状癌中的潜在应用。
Clin Biochem. 2018 Mar;53:127-131. doi: 10.1016/j.clinbiochem.2018.01.008. Epub 2018 Jan 31.

引用本文的文献

1
The Influence of Micronutrients and Environmental Factors on Thyroid DNA Integrity.微量营养素和环境因素对甲状腺DNA完整性的影响。
Nutrients. 2025 Jun 21;17(13):2065. doi: 10.3390/nu17132065.
2
Thyroiditis and Thyroid Cancer: Bioinformatics Analysis of Gene Expression Data.甲状腺炎和甲状腺癌:基因表达数据的生物信息学分析。
In Vivo. 2024 Sep-Oct;38(5):2205-2213. doi: 10.21873/invivo.13684.
3
Bayesian inference of sample-specific coexpression networks.贝叶斯推断样本特异性共表达网络。

本文引用的文献

1
Significance of BRAF mutation in intra-axial brain tumor in Malaysian patients: case series and literature review.马来西亚患者颅内脑肿瘤中 BRAF 突变的意义:病例系列和文献复习。
Exp Oncol. 2021 Jun;43(2):159-167. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-2.16076.
2
Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.利用下一代测序技术对选定的波兰乳腺癌患者肿瘤组织进行突变检测。
Genes (Basel). 2021 Apr 2;12(4):519. doi: 10.3390/genes12040519.
3
Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments.
Genome Res. 2024 Oct 11;34(9):1397-1410. doi: 10.1101/gr.279117.124.
4
[Screening for Characteristic Genes of Different Traditional Chinese Medicine Syndromes of Psoriasis Vulgaris: A Study Based on Bioinformatics and Machine Learning].[寻常型银屑病不同中医证型特征基因的筛选:基于生物信息学和机器学习的研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 20;55(2):337-345. doi: 10.12182/20240360402.
5
Bayesian Optimized sample-specific Networks Obtained By Omics data (BONOBO).通过组学数据获得的贝叶斯优化样本特异性网络(BONOBO)
bioRxiv. 2023 Nov 17:2023.11.16.567119. doi: 10.1101/2023.11.16.567119.
6
Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer.抗氧化状态和DNA修复能力的变化与甲状腺乳头状癌患者恶性甲状腺组织中的分子改变相互印证。
Front Mol Biosci. 2023 Aug 24;10:1237548. doi: 10.3389/fmolb.2023.1237548. eCollection 2023.
癌症信号通路:治疗靶点、联合治疗及新进展。
Cells. 2021 Mar 16;10(3):659. doi: 10.3390/cells10030659.
4
Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.汉族人群 RAS 家族基因突变与甲状腺乳头状癌的交互作用分析。
Int J Med Sci. 2021 Jan 1;18(2):441-447. doi: 10.7150/ijms.50026. eCollection 2021.
5
Prevalence of mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review.亚洲乳头状甲状腺癌系列中突变的患病率——一项当代系统评价
Gland Surg. 2020 Oct;9(5):1878-1900. doi: 10.21037/gs-20-430.
6
Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management.PALB2功能的分子机制及其在乳腺癌治疗中的作用
Front Oncol. 2020 Feb 28;10:301. doi: 10.3389/fonc.2020.00301. eCollection 2020.
7
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.美国内分泌外科学会成人甲状腺疾病确定性手术管理指南。
Ann Surg. 2020 Mar;271(3):e21-e93. doi: 10.1097/SLA.0000000000003580.
8
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
9
Thyroid Cancer in the Pediatric Population.儿童甲状腺癌。
Genes (Basel). 2019 Sep 18;10(9):723. doi: 10.3390/genes10090723.
10
Be careful with your principal components.注意你的主成分。
Evolution. 2019 Oct;73(10):2151-2158. doi: 10.1111/evo.13835. Epub 2019 Sep 2.